Zobrazeno 1 - 6
of 6
pro vyhledávání: '"B G, Utterback"'
Publikováno v:
Receptor. 3(4)
Arg-Gly-Asp-Ser (RGDS) 1, Arg-Val-Asp-Ser (RVDS) 2, Arg-dVal-Asp-Ser (R[d]VDS) 3, and a cyclic RGD peptide, cyclo S,R [H-Pen-Arg-Gly-Asp-Pen-Gly-OH] 4, were tested for their ability to antagonize GPIIb-IIIa function. The activities were found to fall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::757edf7889f03fcd213cbc2aa61a2328
https://pubmed.ncbi.nlm.nih.gov/8142908
https://pubmed.ncbi.nlm.nih.gov/8142908
Autor:
G P, Dubé, D E, Mais, J A, Jakubowski, K A, Brune, B G, Utterback, T A, True, L E, Rinkema, W L, Kurtz
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 262(2)
The stereoisomers of S-145, a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor ligand, were compared to TXA2/PGH2 receptor antagonists, SQ29548 and BM13505 in guinea pig platelets, aortas and trachea. Equilibrium binding assays in platelets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c25aca2ddc6af31778defc60720948d
https://pubmed.ncbi.nlm.nih.gov/1386888
https://pubmed.ncbi.nlm.nih.gov/1386888
Autor:
C V, Jackson, V G, Crowe, J D, Frank, H C, Wilson, W J, Coffman, B G, Utterback, J A, Jakubowski, G F, Smith
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 261(2)
The antithrombotic activity of the tripeptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), was compared to heparin in a model of canine coronary artery thrombosis. Thrombogenesis was initiated by electrolytic injury of the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0452a2d42a45b143733e3d7e89f59bb
https://pubmed.ncbi.nlm.nih.gov/1578372
https://pubmed.ncbi.nlm.nih.gov/1578372
Publikováno v:
Molecular pharmacology. 30(6)
LY195115 selectively inhibited the peak III isozyme of cardiac cyclic nucleotide phosphodiesterase (PDE) eluted from DEAE-cellulose columns. Inhibition curves were biphasic, suggesting heterogeneity within this preparation. Since peak III PDE is repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f298fe34d45d374e54677f8ae446f48d
https://pubmed.ncbi.nlm.nih.gov/2946929
https://pubmed.ncbi.nlm.nih.gov/2946929
Autor:
D R, Holland, J H, Wikel, R F, Kauffman, J K, Smallwood, K M, Zimmerman, B G, Utterback, J A, Turk, M I, Steinberg
Publikováno v:
Journal of cardiovascular pharmacology. 14(3)
Compound LY249933 and its component diastereomers, (RR) and (SR), were studied for their vascular and cardiac effects in vitro and in vivo. In guinea pig cardiac ventricular membranes, LY249933, (RR), and (SR) potently displaced bound [3H]nitrendipin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7082095f16557a8dd86f864c31e9706a
https://pubmed.ncbi.nlm.nih.gov/2476630
https://pubmed.ncbi.nlm.nih.gov/2476630
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 242(3)
Several novel cardiotonic vasodilators including bipyridines (amrinone and milrinone), imidazolones (enoximone and piroximone), dihydropyridazinones (Cl-914, Cl-930 and LY195115) and an imidazopyridine (isomazole) relaxed rat aortic strips contracted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e3ffb8499a7879d85ae7cdd08167520
https://pubmed.ncbi.nlm.nih.gov/2821228
https://pubmed.ncbi.nlm.nih.gov/2821228